<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04752241</url>
  </required_header>
  <id_info>
    <org_study_id>DS-041</org_study_id>
    <nct_id>NCT04752241</nct_id>
  </id_info>
  <brief_title>Preservation of Inferior Mesenteric Artery Could Improve Sexual Function After Laparoscopic Colorectal Resection for Diverticular Disease</brief_title>
  <acronym>IMAPSEX</acronym>
  <official_title>Preservation of Inferior Mesenteric Artery Could Improve Sexual Function After Laparoscopic Colorectal Resection for Diverticular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate whether IMA sparing may represent an advantage in terms of&#xD;
      reduced incidence and severity of sexual dysfunctions after colorectal resections for&#xD;
      diverticular disease (DD).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled patients were randomly divided into 2 treatment groups. In the first group (IMAP)&#xD;
      the IMA was preserved sectioning the sigmoid arteries near colonic wall while, in the second&#xD;
      group (IMAS) the IMA was sectioned immediately below the origin of the left colic artery.&#xD;
      Incidence and severity of sexual dysfunction and QoL were assessed by four validated&#xD;
      questionnaire administered 6,12 months and 5 and 8 years after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2004</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sexual Function Male 1</measure>
    <time_frame>12 month after surgery</time_frame>
    <description>assess the patients' sexual disorders with International Index of Erectile Function (IIEF)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual Function Male 2</measure>
    <time_frame>5 years after surgery</time_frame>
    <description>assess the patients' sexual disorders with International Index of Erectile Function (IIEF)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual Function Male 3</measure>
    <time_frame>8 years after surgery</time_frame>
    <description>assess the patients' sexual disorders with International Index of Erectile Function (IIEF)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual Function Female 1</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual Function Female 2</measure>
    <time_frame>5 years after surgery</time_frame>
    <description>assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual Function Female 3</measure>
    <time_frame>8 years after surgery</time_frame>
    <description>assess the patients' sexual disorders withFemale Sexual Function Index (FSFI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 1</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 2</measure>
    <time_frame>5 years after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 3</measure>
    <time_frame>8 years after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 4</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 5</measure>
    <time_frame>5 years after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life 6</measure>
    <time_frame>8 years after surgery</time_frame>
    <description>The impact of sexual disorders in QoL was evaluated using EORTC QLQ-CR29</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Sexual Function Disturbances</condition>
  <arm_group>
    <arm_group_label>IMAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inferior Mesenteric Artery Preservation Performing left hemicolectomy and anterior rectal resection the IMA was preserved ligating close to the colonic wall the sigmoids arteries.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMAS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inferior Mesenteric Artery Ligation Performing left hemicolectomy the IMA is ligated and sectioned after the origin of left colic artery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inferior Mesenteric Artery Preservation</intervention_name>
    <description>Performing left hemicolectomy the IMA was preserved ligating close to the colonic wall the sigmoids arteries.</description>
    <arm_group_label>IMAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inferior Mesenteric Artery Ligation</intervention_name>
    <description>Performing left hemicolectomy the IMA is ligated and sectioned after the origin of left colic artery</description>
    <arm_group_label>IMAS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diverticular disease&#xD;
&#xD;
          -  Diverticulitis&#xD;
&#xD;
          -  BMI under 35 Kg/mq&#xD;
&#xD;
          -  ASA score from I to III&#xD;
&#xD;
          -  Standardized sigmoid, left colon or rectal resection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  complicated diverticulitis (Hinchey III-IV)&#xD;
&#xD;
          -  previous abdominal surgery or prostatic and/or gynecological resections&#xD;
&#xD;
          -  adverse local condition or the need of multiorgan resection or stoma creation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Andrea</name>
      <address>
        <city>Rome</city>
        <zip>00188</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Francesco Saverio Mari, MD, PhD, FACS</investigator_full_name>
    <investigator_title>MD, PhD, FACS</investigator_title>
  </responsible_party>
  <keyword>Sexual function</keyword>
  <keyword>Colonic diverticular disease</keyword>
  <keyword>Inferior mesenteric artery-preserving</keyword>
  <keyword>Neosigmoid Denervation</keyword>
  <keyword>Postoperative sexual dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticular Diseases</mesh_term>
    <mesh_term>Diverticulum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

